Drug · DIN 02103729
ZESTORETIC
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 28, 2022; first marketed December 31, 1994.
- Drug Identification Number (DIN)
- 02103729
- Company (DIN owner)
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Lisinopril and diuretics C09BA03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LISINOPRIL | 10 MG | |
| HYDROCHLOROTHIAZIDE | 12.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 21, 2021: NOC 26310New Drug Submission (NDS) · Change in product ownerhsip
- February 15, 2000: NOC 1268New Drug Submission (NDS)
- June 20, 1994: NOC 5372Supplement to a New Drug Submission (SNDS) · New strength
Other DINs named ZESTORETIC
- DIN 02045729 · Marketed
- DIN 02045737 · Marketed